Annual Report 2025 The Foundation for Advancement of Essential Diagnostics (FAED)
At a Glance FAED Highlights
2025 Milestones
Projects &
Our Model and
Our People
Collaborations
Processes
Looking Ahead
Page 1 of 24
Foreword "The impact we dream to have in every patient’s life drives every effort we make. If we stay true to our values and remain tenacious in our resolve, the future of healthcare delivery is ours for the taking.” Mustafa Barbhuiya, PhD Founder Director This year marked the seventh year anniversary of the foundation. In 2025, the FAED in India achieved several milestones. The successful renewal of DSIR-SIRO, Govt of India recognition up to 2027 has been a great team effort. The FAED team has been conducting a needs and gaps assessment of diagnostic availability across health systems in India. The collaborative work expanded to Tripura, West Bengal, Karnataka, Punjab, Manipur, Mizoram, Meghalaya, Nagaland, Himachal Pradesh, Delhi-NCR, and Uttar Pradesh through our partners. We plan to maintain momentum to nearly cover all states and union territories through FAED activities in 2026. FAED has continued efforts in identifying anemia hot spots in several poverty-stricken districts in Assam and developing intervention models based on the recommendations of ‘Anemia Mukt Bharat’ campaigns and other scientific intervention models. Our efforts to end TB through screening, diagnosing, and appropriately treating the TB patients remain a cornerstone to eliminate TB from India. FAED participated as a Nikshay Mitra for 100 TB patients as part of civic engagement efforts under the Nikshay Poshan Yojana. These efforts are learning opportunities to innovate in the last-mile healthcare delivery. We envision several of these activities, which are relevant to the healthcare needs of people in North East India, continuing. In the coming years, the FAED will expand its 3D Mission activity pan-India around primary healthcare delivery, as mentioned in this report. We have over 1.5 billion people in India. Approximately 70% currently live in 650,000+ villages, with a highly informal healthcare delivery system. We will keep them in mind as we expand our activities in 2026 and beyond. The impact we aim to have on every patient’s life drives every effort we make within FAED. If we stay true to our values and remain tenacious in our resolve, the future of healthcare delivery is ours to seize. We are grateful to funding agencies, scientific collaborators, donors, volunteers, friends, and supporters for their support on our journey. We have a learned scientific advisory board and an institutional ethics committee, to whom we are grateful for their guidance. Looking forward to your continued support in this journey. On behalf of the Team FAED, I wish you a delighted, healthy, and prosperous new year in 2026. Mustafa Barbhuiya, December 31, 2025 Page 2 of 24
FAED- The Organization Foundation for Advancement of Essential Diagnostics (FAED) is a Section 8 non-profit organization registered on Nov 19, 2018. FAED is a recognized Scientific and Industrial Research Organization (SIRO) by the Department of Scientific and Industrial Research (DSIR), Ministry of Science and Technology, Govt. of India. FAED is committed to research and development in the areas of clinical laboratory management, pathology, laboratory medicine, and diagnostics. FAED aims to augment the ‘Essential Diagnostics List’ (EDL) of the World Health Organization and implement it in the Indian health care system. Vision: To improve public health by preventing avoidable deaths through accurate and timely diagnoses. Mission: To provide affordable and accessible diagnostic and healthcare services to underserved communities in India, with plans to expand to Southeast Asia. Core Purpose: To deliver high-quality laboratory medicine services for accurate and timely disease diagnosis to underserved populations. Core Values: A commitment to advancing human health and life through the principle of ‘One World, One Health’.
FAED Highlights
FAED Snapshot 2025
https://www.youtube.com/shorts/m7r5R2MGqTA Page 3 of 24
FAED HIGHLIGHTS FAED received grant support from the Association for India’s Development (AID), USA. FAED successfully supported over 3000 people in Assam, India, with health interventions as part of the medical relief in response to seasonal floods. FAED followed up with the previous year's health camp beneficiaries
and
successfully
conducted
annual
physical examinations with the help of the medical team, providing clinical consultations for over 500 people in Assam, India. FAED
has
extended
Diagnostic List
its
(NEDL)
ICMR
National
availability
Essential
survey
beyond
Northeast India to Punjab, Haryana, Uttar Pradesh, Rajasthan,
Karnataka,
and
Delhi-NCR,
assessing
diagnostic infrastructure in public health settings This year, FAED successfully secured the renewal of its Department of Scientific and Industrial Research (DSIR)–Scientific and Industrial Research Organization
(SIRO) recognition, valid until 2027. FAED provided nutritional support as a Nikshay Mitra for 100 tuberculosis patients and will continue the activity.
FAED at BioNEST FAED
office,
and
space
in
BioNEST-
the
lab
TIDF, Research Park, IIT Guwahati, Assam. The lab space provides access to research
facilities
and
equipment
on
the
IIT
campus
to
support
FAED's ongoing research and innovation. Page 4 of 24
Comprehensive Medical Relief for Displaced Tribal Communities of Manipur On February 9th, 2025, the FAED team carried out a camp at the refugee camp at Fulertol, Lakhipur Cachar. Doctors provided medical consultations, free medication, and identified individuals requiring follow-up care. Assessed basic health parameters, particularly for women and children. A total of 487 individuals benefited from the project. A total of 66 individuals were screened for BMI, blood pressure, and infections. This was a sequel of follow-up camps to the May 2025 violent clashes between the Meitei and tribal (Kuki and Hmar) communities in Manipur, which led to severe displacement, casualties, and destruction of property. Over 46,000 people were evacuated, with 1,809 houses burned and hundreds of injuries reported. A large number of displaced individuals sought refuge in the Cachar district
of Assam—primarily in Fulertol, Hmarkhawlien, and
Lalpani areas. These
communities
face
persistent
challenges
including lack of healthcare, food insecurity, inadequate shelter, poor hygiene, and disrupted education. Earlier In 2024, FAED promptly collaborated with local government medical teams, conducted a detailed health assessment for the displaced communities. The first major health camp was held on September 19, 2024, at Hmarkhawlien village in Cachar district. This year, our efforts continued to support these members of the affected community. Assessed basic health parameters, particularly for women and children. Distributed essential food supplies and medicines to all displaced individuals. Conducted awareness programs and distributed hygiene materials. Provided winter clothing and relief material to the displaced population. FAED’s Comprehensive Medical & Winter Relief initiative has significantly contributed to improving the health, nutrition, and living conditions of the displaced tribal communities from Manipur. Despite operational challenges, the program successfully met its objectives and established a foundation for continued humanitarian engagement. FAED remains committed to supporting vulnerable populations through sustained relief, healthcare, and awareness interventions in coordination with local authorities and partners.
Page 5 of 24
Nutritional & Healthcare support for flood affected communities in Assam The Barak Valley in Assam experienced one of its most severe floods in 2025, affecting more than 6.33 lakh people across 21 districts. The deluge, worsened by climate change and inadequate flood management, resulted in widespread damage to homes, croplands, and health infrastructure. The districts of Silchar, Sribhumi, and Hailakandi were among the worst affected, with extensive displacement and food insecurity. In response, the Foundation for Advancement of Essential Diagnostics (FAED), with financial support from the Association for India’s Development (AID), initiated the project 'Holistic Nutritional and Healthcare Support for Communities Recently Affected by Floods in Assam’s Barak Valley'. The project aimed to deliver immediate nutritional and medical relief, promote health awareness, and build community resilience through data-driven interventions. Immediately after the flood, FAED teams conducted field surveys in flood-affected areas to determine the extent of damage and identify the most vulnerable communities. Following the flood event, FAED teams conducted a rapid needs assessment to identify areas requiring urgent intervention. The survey focused on parameters such as population displacement, food availability, and access to medical services. Based on the findings, three locations — Suprakandi village in Sribhumi District, Nitai Nagar & Cheptibrojopur villages of Hailakandi and Udharbond circle in Cachar District — were prioritized for immediate action. These areas exhibited severe food shortages, damaged infrastructure, and a large number of vulnerable families.
Flood relief camps were conducted at Sribhumi and Cachar, Assam. Organized by FAED with support from AID (USA).
Page 6 of 24
Supplied essential nutritional and Medical Relief Materials to the Most Affected Population Health Protection and Awareness Initiative for Flood-Affected Communities After both camps, all collected data was compiled and analyzed. The total number of individuals benefited from this intervention was approximately 2367 people, distributed equally by gender.
The timely support from AID, USA enabled FAED to respond quickly and effectively to the crisis in Barak Valley. By combining immediate relief with basic health assessment, this intervention provided both urgent aid and insight into ongoing health challenges in the region. FAED remains committed to reaching the remaining affected districts and ensuring long-term recovery and resilience for floodimpacted communities.
ICMR Recommended National Essential Diagnostic List (NEDL) availability survey To improve access to diagnostic services, the World Health Organization (WHO) launched the Essential Diagnostics List (EDL) in 2018. The WHO EDL aims to standardize diagnostic tests, reduce costs, and improve quality across all levels of healthcare. Following this, India developed its National Essential Diagnostics List (NEDL) in 2019. India’s healthcare system is organized into three tiers: primary (SubCentres and Primary Health Centres), secondary (Community Health Centres and Sub-District Hospitals), and tertiary (District Hospitals and Medical Colleges). In this project, we assessed the availability of essential diagnostic tests in public health facilities in accordance with the ICMR NEDL 2019 guidelines. To date, we have surveyed 327 public health facilities across eight states and the Union Territory of Delhi, covering 24 districts. To assess the availability of essential diagnostic tests in public health facilities as per the ICMR National Essential Diagnostics List (NEDL-2019). To compare diagnostic availability across different levels of healthcare (primary, secondary, and tertiary) in selected states, districts, and Delhi. The work has been either published, under peer-review and presented in international forums. Our survey identified substantial deficiencies in the availability of diagnostics listed on the National Essential Diagnostics List (NEDL) across public healthcare facilities. These gaps were most pronounced in rural and geographically challenging regions of India. The findings underscore an urgent need to strengthen diagnostic infrastructure, capacity, and service delivery at the primary healthcare level to
ensure equitable access to essential diagnostics. Page 7 of 24
Select images of surveyed sites at different healthcare centers.
Page 8 of 24
Nutritional support for TB-patients as Nikshay Mitra Tuberculosis (TB) remains a major public health challenge in India, particularly among socioeconomically vulnerable populations. Poor nutritional status weakens immunity, increases the risk of developing active TB, delays recovery, and raises the chances of treatment failure and mortality. Although the Government of India has introduced the Nikshay Poshan Yojana (NPY) to provide financial assistance to TB patients for nutritional support, several gaps remain in timely disbursement, adequacy of support, and utilization of the incentive for appropriate nutrition. In many districts, TB patients continue to suffer from food insecurity, anemia, weight loss, and co-morbidities such as diabetes. Women, elderly patients, migrant workers, and daily wage earners are particularly vulnerable. There is a critical need for a community-based TB nutrition support (TB Poshan) initiative that complements the national program by ensuring direct access to nutritious food, regular nutrition counselling, and close follow-up during the treatment period. This proposal outlines a TB Poshan Program aimed at improving the nutritional status, treatment adherence, and overall outcomes of drug-sensitive and drug-resistant TB patients through structured nutritional support and community engagement. To provide monthly nutrition kits to TB patients for the full duration of their treatment. Effort to improve body weight, BMI, and hemoglobin levels of enrolled TB patients. Enhance treatment adherence and reduce loss to follow-up. Create awareness about TB nutrition through counseling and community education. Support vulnerable TB patients who are unable to meet basic dietary requirements to augment existing government schemes.
Nutritional kit distribution to 100 TB patients of Cachar by FAED as Nikshay Mitra at SM Dev Civil Hospital, Silchar, Cachar, Assam.
Page 9 of 24
Key outcomes: Coordination with District TB Office (DTO), TB Health Visitors, ASHA workers, and DOTS centers. Verification of 100 patients through Nikshay portal. Informed consent and baseline assessment of weight, BMI, hemoglobin, and socio-economic status. Individualized counseling for patients at the time of kit distribution. Provided guidance on balanced diet, protein intake, hydration, and anemia management. We are registered under the Nikshay Mitra scheme and have distributed nutritional support kits to 100 tuberculosis (TB) patients. We have set a target to provide comprehensive nutritional support for 900 economically disadvantaged TB patients in rural Assam for one year.
Reconnecting to the roots of the Neglected Tropical Diseases (NTDs)
Sir Ronald Ross, KCB KCMG FRS FRCS was a British physician scientist, born in Almora, India, who received the Nobel Prize for Physiology or Medicine in 1902 for his work on the transmission of malaria, becoming the first British Nobel laureate, and the first born outside Europe. The historic Labac Tea Estate Hospital near Silchar, Assam, India is where he conducted crucial malaria research; his equipment is preserved as a living museum. He worked there in the late 1890s, discovering the link between mosquitoes and malaria, and his legacy is honored at this location, which has historical medical tools and displays. FAED’s Dr. Biswajit Chakraborty visited this site, as seen in the photos above. FAED is actively pursuing collaborations with the Labac Tea Estate Hospital to revive the lost glory of Ross Lab
Page 10 of 24
Establishment of a Model Polyclinic in Cachar, Assam
During the year, FAED initiated a strategic intervention to establish an integrated polyclinic model in a selected area of Cachar district, Assam, to strengthen access to essential healthcare services for rural and underserved populations. The initiative is aligned with state and central government regulations and the specific aim of enhancing primary care service delivery. The project is currently in the preparatory phase, including finalizing the land agreement, completing statutory registration, and developing infrastructure in phases to operationalize the polyclinic.
Preparatory phase of FAED polyclinic set-up at the Cachar district of Assam.
Page 11 of 24
Institutional Ethical Committee (IEC) Meeting
The IEC meeting was convened for the approval of proposed FAED projects, attended by Dr. Alak Buragohain, Dr. Rajlakshmi Devi, Mrs. Geetimala Baishya, Dr. Nawaz S. Laskar, Dr. Amaj Laskar, Ms Anamika Baruah and Dr. Biswajit Chakraborty. Dr. Zeeshan Mustafa and Dr. Mustafa Barbhuiya attended via zoom.
Page 12 of 24
FAED at Global Forums
Dr. Mustafa Barbhuiya was an invited speaker at the MedLab Middle East Conference. Describe the WHO Essential Diagnostics List (EDL) and its role in global healthcare delivery Define Point of Care Testing (POCT) and discuss the opportunities for innovation Disease burden, regional prevalence and diagnostic needs assessment to identify areas of POCT implementation and innovation Understand artificial intelligence (AI) enabled POC diagnostic tools, limitations, and regulatory predicament.
Page 13 of 24
FAED at Global Forums
During the Association of Clinical Scientists (ACS) Annual Meeting, May 14 -17, 2025, at the Warren Alpert Medical School of Brown University, Providence, RI, USA. Dr. Barbhuiya presented FAED activities on the diagnostic availability of clinical tests relevant to neglected tropical diseases.
American Society for Clinical Pathology (ASCP), Annual Meeting, November 17-20, 2025, Atlanta, Georgia, USA.
Refer to the abstracts in published conference proceedings: 143:https://academic.oup.com/ajcp/article/164/Supplement 1/aqaf121.334/8320867 164: https://academic.oup.com/ajcp/article/164/Supplement_1/aqaf121.056/8320799
Page 14 of 24
Our Dogma of Healthcare Delivery
Laboratory Medicine is Fundamental to Healthcare Delivery and Improving Population Health: https://www.youtube.com/watch?v=VEztMt9HmG0 What is the Essential Diagnostics List: https://www.youtube.com/watch?v=2JfdLGK0Mw8 Why Essential Diagnostics is Important: Making a Difference in Every Patient's Lives: https://www.youtube.com/watch?v=2IIv-itSNqk
Community engagement for
Multilingual Public Health
Data Analytics & Disease
Healthcare Delivery
Communication
Dynamics
Page 15 of 24
Our Model and Processes Our three-dimensional model is based on innovation, evidence generation, and integration of CRE in healthcare delivery.
Innovation
Evidence generation
Page 16 of 24
Integration of CRE
Our People People are the driving force of this organization. It is our commitment to provide an empowering and supportive environment that enables team members to fulfill their dreams and maximize their potential through impactful work in FAED's mission areas. This will ensure a long-term positive impact on everyone’s lives and livelihoods as we work to solve complex healthcare delivery problems for millions. We have established new collaborations and have new hands on deck who are equally enthusiastic about healthcare delivery and serving the community. This year, FAED has made progress by expanding its activities nationwide. Read more below. Founder and Director, Dr. Mustafa Barbhuiya was featured in the American Society of Cliical Pathology (ASCP) series on ‘A Decade of ASCP’s 40 Under Forty (Ref: Mustafa Barbhuiya ) He said
on
a
question “What is the biggest lesson you’ve learned in the years since being named a 40 Under Forty?
‘Read to lead and knowledge is power. Be that specific resource person where colleagues and physicians can confidently consult you on that difficult call around 1500+ chemical pathology tests and test interpretations. You will have all of their back and lean on you that is an intensely gratifying job. My life’s mission is “bringing laboratory medicine to the forefront of local and global healthcare delivery.” I am
Founder Director:
Dr. Mustafa Barbhuiya
proud that I identified my life’s goal and mission.’ Dr. Barbhuiya Meet our new member: Dr. Zeeshan Mustafa He joined as a Staff Scientist at FAED. He is a dedicated infectious disease expert with a Ph.D. in Microbiology from the Department of Microbiology, Jawaharlal Nehru Medical College, Aligarh Muslim University (AMU), Aligarh, India. With over six years of research and teaching experience in molecular virology and microbiology, Dr. Mustafa has developed a robust expertise in both academic and diagnostic settings. Currently, at FAED, Dr. Zeeshan Mustafa focuses on neglected tropical diseases (NTDs) and associated diagnostic availability and access gaps to address challenges in last-mile healthcare delivery. His future research interests are in vitro diagnostic assay development, antiviral and antimicrobial drug discovery, and the study of virus-host interactions, particularly in the context of emerging infectious diseases, NTDs, and immunopathology. Read more at : https://faed.in/?pg=team
Page 17 of 24
New member: Dr. Zeeshan Mustafa
Page 18 of 24
Projects submitted to funding agencies Multiplex Isothermal LAMP Assay for Rapid Point-of-Care Detection of Visceral Leishmaniasis, Malaria, and Lymphatic Filariasis in Co-Endemic Areas. A Novel Multiplex Real-time RT-PCR Platform for Differential Diagnosis and Surveillance of Arboviral Co-infections.
Publications Chakraborty B, Laskar AA , Mustafa Z, Kumar V, Kumar R, Arora K, Barbhuiya AH, Hussain AA, Parvin A, Singh LM, Shil K, Roy S, Baruah A, Barbhuiya MA. Evaluating the Nationwide Availability of Essential Diagnostics for Tuberculosis Towards Achieving a TB-free India. Available at SSRN: https://ssrn.com/abstract=5494115 or http://dx.doi.org/10.2139/ssrn.5494115 (Pre-print with The Lancet, September 30, 2025) Chakraborty B, Laskar AA, Baruah A, Kumar R, Barbhuiya MA. Critical Perspectives on Global Health Policy, Diagnostic Access and Practice Gaps towards a Tuberculosis Free India. Ann Clin Lab Sci. 2024 Nov;54(6):721-738. Chakraborty B, Nath S, Deb S, Baruah A, Paul M, Dutta SS, Barbhuiya MA. Analytical and Clinical Performance of Two Point of Care Rapid Antibody Assays for SARS-CoV-2. Ann Clin Lab Sci. 2023 May;53(3):353-359.
Looking forward to 2026 A study on clinical reference intervals for diabetes and cardiovascular risk assessment across different ethnic groups in North East India. Extension of the nationwide survey on the availability of diagnostic tests compared to the NEDL list of ICMR.
Assessment of treatment outcomes in tuberculosis patients with or without supplemental nutrition coupled with Nikshay Poshan Support. Indigenous In Vitro Diagnostic Test development for tuberculosis, arboviral fevers, and other Neglected Tropical Diseases Indigenous In Vitro Diagnostic Test development for targeted therapy selections, mutation screening in Cancers relevant to the Indian population Setting up the first model integrated polyclinic towards providing a solution to last-mile healthcare delivery
Page 19 of 24
Scientific Advisory Board Scientific Advisory Board (SAB) of the Foundation for Advancement of Essential Diagnostics (FAED) consists of the following members: Sl. No. Name
Affiliation
Area of Expertise
Designation
1
Dr. Lee Schroeder (MD, PhD)
Associate Professor, Chemical Lee Schroeder’s global work focuses Member Pathology; Director of Point of Care on using decision analytic approaches Testing; Associate Director, to model and improve the impact of Chemical Pathology; Department laboratory medicine, specifically in of Pathology Michigan Medicine, low- and middle-income countries. University of Michigan, USA
2
Dr. Timothy Amukele (MD, PhD)
Global Medical Director for Icon Clinical Laboratories; President, Pathology Overseas
3
Dr. Barb Jones (PhD)
Chief Executive Officer, Clinical Dr. Jones’ experience includes Member Laboratory Standard Institute, USA operations leadership, laboratory management, pharmaceutical and quality standards development, regulatory policy, and business development at both the national and international levels.
4
Himangshu Sekhar Das
Former Additional Chief Secretary Information and Human Rights and State Chief Information Commissioner, Assam. Presently, Special Monitor, National Human Rights Commission, Delhi
Member
5
Dr. Rajlakshmi Devi
Professor and Head, Department of Life Sciences Life Sciences, Institute of Advanced Study in Science and Technology (IASST), Guwahati
Member
6
Dr. Sriparna Baruah
Retd. Head- Centre for Industrial Extension, Indian Institute of Entrepreneurship (IIE), AdvisorNEHHDC, Margdarshak Advisory, Guwahati
Business and Entrepreneurship
Member
7
Dr. Simanta Borah
Medical Consultant, Reserve Bank of India, Guwahati
Medical Consultant
Member
Tim is deeply invested in seeing Member improvements in access to high quality Pathology and Laboratory Medicine (PALM) services in countries around the world.
Page 20 of 24
Institutional Ethical Committee The Institutional Ethical Committee (IEC) was constituted with members from scientific, social, medical and legal backgrounds. The IEC is responsible for examining ethical and legal aspects of the company's various projects. The present IEC consists of the following members: Sl. No. Name
Affiliation
Area of Expertise
1
Dr. Alak Buragohain
Chancellor, Girijananda Choudhary University, Sr. Scientist from Life Former Vice Chancellor of Dibrugarh Science University, Former HoD, MBBT Department, Tezpur University, Assam
2
Dr. Monojit Paul MD Microbiologist, Medical & Health Officer 1(M&HO1), Fulbari PHC, Assam, India
Scientist from Medical Practice
Member
3
Dr. Rajlakshmi Devi
Professor & Head, Department of Life Sciences, Institute of Advanced Study in Science and Technology (IASST), Guwahati
Basic Sciences / Researcher
Member
4
Mrs. Geetimala Baishya
Retd. General Manager of Assam Industrial Development Corporation (AIDC) Ltd, Guwahati, Assam
Social Scientist /Philosopher/Social Activist
Member
5
Dr. Mustafa A Barbhuiya
Founder and Director, FAED, BioNEST BioIncubation Centre, Indian Institute of Technology, Guwahati-781039, Assam, India
Basic Sciences / Researcher
Member
6
Ms. Anamika Baruah
Director, Administrative & Communication, FAED, BioNEST Bio-Incubation Centre, Indian Institute of Technology, Guwahati-781039, Assam, India
Social Scientist /Philosopher /Social Activist
Member
7
Dr. Amaj Ahmed Director, FAED, BioNEST Bio-Incubation Centre, Indian Institute of Technology, Laskar Guwahati-781039, Assam, India
Basic Sciences / Researcher
Member
8
Dr. Biswajit Chakraborty
Basic Sciences / Researcher
Member Secretary
9
Mr. Manash Das Advocate, Guwahati High Court, Guwahati, Assam
Legal Advisor
Member
Research Scientist & Principal Investigator, FAED, BioNEST Bio-Incubation Centre, Indian Institute of Technology, Guwahati-781039, Assam, India
Page 21 of 24
Designation Chairperson
“What we have done for ourselves alone dies with us; what we have done for others and the world remains and is immortal” ~ Albert Pike
Looking Ahead We aim to expand our activities pan-India. We have pending funding applications with several grant agencies. We strive to raise Rs. 100,00,000/- (Rupees One Crore only; approximately USD120,000/-) for the next fiscal year to continue the activities of the FAED mission area. Especially, the establishment of the physical infrastructure in the form of model polyclinic that is under development.
Financial Outlook Fiscal Year is April 1 to March 31; The audited reports of each financial year are made public in the website www.faed.in FAED is thankful to the Association for India’s Development, USA for generous supports to carry out several projects The 2026 outlook depends on the grants, donations, and funds received We are looking for partners, collaborators, and supporters. We appeal to the philanthropic organizations, individual donors, and funding agencies to support the programs of FAED. We also look forward to participating in the competitive call for proposals. For specific questions please send an email to admin@faed.in copy to mabarbhuiya@faed.in
Page 22 of 24
Further Information Official Website: www.faed.in
Foundation for Advancement of Essential Diagnostics (FAED)
Previous Year Annual Reports: https://faed.in/?pg=annual_reports Audit Report: https://faed.in/?pg=audit_reports Publications and articles: https://faed.in/?pg=publications Press and Media: https://faed.in/?pg=press_media
FAED in Social Media: Facebook:
Foundation for Advancement of Essential Diagnostics - FAED
LinkedIn: https://www.linkedin.com/company/foundation-for-advancement-of-essentialdiagnostics/?viewAsMember=true YouTube:
FAED the Essential Diagnostic Odyssey
Page 23 of 24
Contact Us For further information, please reach out to us at admin@faed.in Registration & Accreditation
FAED
· CIN: U73200AS2018NPL018870
BioNEST Bio-Incubation Centre Indian Institute of Technology, Guwahati
· PAN: AADCF5651Q
781039, Assam, India
· 12A/80G: AADCF5651Q24KL01 · CSR: SRN-T94944113
Email: admin@faed.in
· DARPAN ID: AS/2021/0298848
Website: www.faed.in
· DIPPP NO: DIPP78683
Donation
· ROC LICENSE NO: 113291 · DSIR SIRO Certification: 14/912/2023-TU-V
Financial contributions from generous donors
· FCRA REG. NO: 020780179
are highly appreciated. They will help FAED achieve its goal of providing health care benefits to society to prevent deaths from preventable causes due to a lack of accurate, timely diagnosis.
You can send donations to: If you are an Indian Citizen Account Name: Foundation for Advancement of Essential Diagnostics Account Number: 198905000835 IFSC : ICIC0001989 Bank Name: ICICI Bank Branch Name: Beltola Branch or If you are donating from abroad and a non-Indian citizen want to support several global health efforts of FAED, please donate using PayPal Giving Fund (EIN: 85-1068018) using link below · https://www.paypal.com/us/fundraiser/charity/4874398 · 501(c)(3) tax-exemption applicable for donations made in the USA. · FAED in India is FCRA registered, and DSIR-SIRO recognized. · FAED is eligible to receive CSR funds (CSR: SRN-T94944113) in India
End of Report
Page 24 of 24